Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Skeletal muscle Atrophy
100%
Small Molecule Therapy
100%
Compound A
75%
Novel Chemical Entity
58%
Muscle Atrophy
25%
Pharmacological Therapy
16%
FDA Approval
16%
University of Iowa
16%
Skeletal Myotubes
16%
Orthopaedic Trauma
8%
Strength Capacity
8%
Muscle Hypertrophy
8%
Prolonged Hospitalization
8%
Unmet Medical Need
8%
Exercise Capacity
8%
Increased Mortality
8%
Medical Market
8%
Current Therapeutics
8%
Exclusive Licenses
8%
Clinical Impact
8%
Pharmaceutical Development
8%
Critical Illness
8%
Spinal Cord Injury
8%
Commercial Potential
8%
Nursing Home Placement
8%
Protein Accretion
8%
Companion Animals
8%
Cellular Hypertrophy
8%
Toxicology Studies
8%
Fall-related Fracture
8%
Phase I Study
8%
Therapeutic Approaches
8%
Pharmacokinetic Study
8%
Intellectual Property
8%
Human Animals
8%
Renal Failure
8%
Rehabilitation nursing
8%
Reducing Activity
8%
Advanced Age
8%
Bed Rest
8%
Nutrition Rehabilitation
8%
IND Application
8%
Orthopaedic Patients
8%
Diabetes
8%
Pharmacologic
8%
Effective Compounds
8%
Heart Failure
8%
Small Molecules
8%
Physical Rehabilitation
8%
Medical Problems
8%
Pharmacology, Toxicology and Pharmaceutical Science
Muscle Atrophy
100%
Lead Compound
6%
Relative Efficacy
6%
Toxicology
6%
Pharmacokinetics
6%
Dog
6%
Muscle Growth
6%
Chronic Obstructive Lung Disease
6%
Rat
6%
Congestive Heart Failure
6%
Malignant Neoplasm
6%
Spinal Cord Injury
6%
Critical Illness
6%
Diseases
6%
Clinical Study
6%
Cerebrovascular Accident
6%
Kidney Failure
6%
Weakness
6%